Literature DB >> 25264065

Reconstruction of chronic Achilles tendon rupture using the semitendinosus tendon: a case report.

Makoto Takeuchi1, Naoto Suzue, Tetsuya Matsuura, Kosaku Higashino, Toshinori Sakai, Daisuke Hamada, Tomohiro Goto, Yoichiro Takata, Toshihiko Nishisho, Yuichiro Goda, Ryosuke Sato, Ichiro Tonogai, Kazuaki Mineta, Koichi Sairyo.   

Abstract

Achilles tendon rupture is a common trauma requiring surgical management. For chronic Achilles tendon rupture in particular, reconstructive surgery is desirable and several methods have been described. Here we present a case of chronic Achilles tendon rupture reconstructed using the semitendinosus tendon because of the difficulty in pulling down the proximal stump to reach the distal stump and due to an insufficient margin for hooking a suture to the distal stump. Postoperatively, the patient had a fully functional tendon and resumed his normal activities of daily living. Using this surgical technique, we expect favorable outcomes in cases of Achilles tendon rupture.

Entities:  

Mesh:

Year:  2014        PMID: 25264065     DOI: 10.2152/jmi.61.417

Source DB:  PubMed          Journal:  J Med Invest        ISSN: 1343-1420


  3 in total

1.  Good outcomes at mid-term following the reconstruction of chronic Achilles tendon rupture with semitendinosus allograft.

Authors:  Yu-Jie Song; Gang Chen; Shao-Hua Jia; Wei-Bin Xu; Ying-Hui Hua
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2018-08-20       Impact factor: 4.342

2.  Synthesis, development, characterization and effectiveness of bovine pure platelet gel-collagen-polydioxanone bioactive graft on tendon healing.

Authors:  Ali Moshiri; Ahmad Oryan; Abdolhamid Meimandi-Parizi
Journal:  J Cell Mol Med       Date:  2015-02-20       Impact factor: 5.310

3.  Minimally invasive, endoscopic Achilles tendon reconstruction using semitendinosus and gracilis tendons with Endobutton stabilization.

Authors:  Tomasz Piontek; Paweł Bąkowski; Kinga Ciemniewska-Gorzela; Monika Grygorowicz
Journal:  BMC Musculoskelet Disord       Date:  2016-06-03       Impact factor: 2.362

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.